注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Milestone Pharmaceuticals Inc是一家总部位于加拿大的生物制药公司。该公司专注于心血管药物的开发和商业化。其主要候选产品 etripamil 是一种强效短效钙通道阻滞剂,该公司设计并正在开发这种快速起效的鼻腔喷雾剂,供患者使用。该公司正在开发用于治疗心律失常的 etripamil,其适应症是治疗阵发性室上性心动过速(PSVT),随后是治疗心房颤动伴快速心室率(AFib-RVR)和其他心血管适应症。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Philippe Douville | 61 | 2005 | Founder, Strategic Advisor & Member of Scientific Advisory Board |
Harry A. Kopelman | - | - | Member of the Scientific Advisory Board |
John DiMarco | - | - | Member of the Scientific Advisory Board |
Harry Jefferson Leighton | 77 | - | Member of the Scientific Advisory Board |
Debra K. Liebert | 67 | 2015 | Independent Non-Executive Director |
Albert L. Waldo | - | - | Member of the Scientific Advisory Board |
Michael John Tomsicek | 57 | 2019 | Independent Non-Executive Director |
Daniel R. Omstead | 70 | 2017 | Observer |
Joseph G. Oliveto | 55 | 2017 | CEO, President & Director |
Jean-Yves Le Heuzey | - | - | Member of the Scientific Advisory Board |
John Camm | - | - | Member of the Scientific Advisory Board |
Paul Dorian | - | - | Member of the Scientific Advisory Board |
Richard C. Pasternak | 74 | 2019 | Independent Non-Executive Director |
Seth H. Z. Fischer | 67 | 2023 | Independent Non-Executive Director |
Peter R. Kowey | - | - | Member of the Scientific Advisory Board |
Lisa M. Giles | 64 | 2020 | Independent Non-Executive Director |
Robert James Wills | 69 | 2020 | Independent Chairman of the Board |
Philip T. Sager | 68 | 2020 | Chief Medical Advisor & Member of the Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核